CVS Health (NYSE:CVS) Trading Down 0.4% - Time to Sell?

Shares of CVS Health Co. (NYSE:CVS - Get Free Report) traded down 0.4% during mid-day trading on Friday . The stock traded as low as $55.76 and last traded at $56.60. 2,155,784 shares were traded during mid-day trading, a decline of 83% from the average session volume of 12,922,054 shares. The stock had previously closed at $56.82.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of research reports. Barclays dropped their price target on CVS Health from $75.00 to $71.00 and set an "overweight" rating for the company in a research note on Thursday, November 7th. TD Cowen upped their price target on shares of CVS Health from $73.00 to $80.00 and gave the company a "buy" rating in a research note on Monday, November 25th. Royal Bank of Canada dropped their price objective on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a research note on Friday, November 15th. Wells Fargo & Company upgraded shares of CVS Health from an "equal weight" rating to an "overweight" rating and upped their target price for the company from $60.00 to $66.00 in a research report on Monday, November 18th. Finally, Evercore ISI boosted their price objective on CVS Health from $60.00 to $65.00 and gave the stock an "outperform" rating in a research note on Monday. One analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $68.12.

CVS Health Stock Down 0.5 %

The firm has a market capitalization of $71.13 billion, a PE ratio of 14.35, a PEG ratio of 0.62 and a beta of 0.59. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The company has a fifty day simple moving average of $51.27 and a two-hundred day simple moving average of $56.17.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts' consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. During the same quarter last year, the firm posted $2.21 EPS. The company's revenue for the quarter was up 6.3% on a year-over-year basis. Analysts forecast that CVS Health Co. will post 5.18 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be issued a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.71%. CVS Health's dividend payout ratio is presently 67.51%.

Institutional Investors Weigh In On CVS Health

A number of hedge funds have recently made changes to their positions in the stock. State Street Corp lifted its position in shares of CVS Health by 3.6% during the third quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator's stock valued at $3,554,475,000 after buying an additional 1,989,066 shares during the last quarter. Geode Capital Management LLC lifted its position in CVS Health by 1.8% during the third quarter. Geode Capital Management LLC now owns 26,361,673 shares of the pharmacy operator's stock valued at $1,651,997,000 after acquiring an additional 461,569 shares during the last quarter. Pzena Investment Management LLC boosted its stake in CVS Health by 1.5% in the third quarter. Pzena Investment Management LLC now owns 13,135,308 shares of the pharmacy operator's stock valued at $825,948,000 after acquiring an additional 198,920 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in CVS Health by 2.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 12,208,668 shares of the pharmacy operator's stock worth $767,681,000 after purchasing an additional 304,386 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC increased its position in shares of CVS Health by 34.8% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator's stock worth $748,085,000 after purchasing an additional 3,071,613 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.